Mandril, Nur-aine .

HRN: 19-90-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2024
METRONIDAZOLE 500MG (TAB)
04/30/2024
05/07/2024
PO
500mg
TID X 7 Days
Thinly Meconium Stained Amniotic Fluid
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: